Newport Digital Technologies, Inc. (NPDT.OB) Appoints Leonard Makowka M.D. Ph.D. to the Advisory Board

In the company’s news yesterday,

Newport Digital Technologies, Inc. announced that Leonard Makowka M.D. Ph.D. has been appointed to the company’s Advisory Board. Dr. Makowka will assist Newport Digital in the integration and sales of wireless and paperless hospital solutions in North America. These solutions have been successfully developed and implemented in Taiwan through NPDT’s technology partners, The Institute for Information Industry (III) and Industrial Technology Research Institute (ITRI), and will leverage the company’s existing RFID and Wimax technologies.

Dr. Makowka will supervise Newport’s efforts to develop and implement Beta test sites at select major US Hospitals and academic institutions. The company anticipates that the successful integration of these advanced digital technologies will lower administrative and patient costs, while streamlining healthcare operations and improving patient care. Fully scalable on a national level, these programs will lead to seamless, secure and robust networks which directly focus on and address the Nation’s changing health care system.

Dr. Makowka received his M.D. degree from the University of Toronto Medical School in 1977 and Ph.D. from the University of Toronto’s Department of Pathology in 1982. He has published over 400 articles and chapters in both clinical and basic scientific research and has lectured worldwide. Dr. Makowka was the Chairman of the Department of Surgery and the Director of Transplantation Services at Cedars-Sinai Medical Center in Los Angeles, Ca and Professor of Surgery at the UCLA School of Medicine, from 1989 to 1995.

Dr. Makowka retired from the practice of medicine to pursue entrepreneurial interests. He has been involved in numerous capacities (including founder, board member, officer and consultant) in numerous healthcare, life science and technology companies, both private and public.

“We are pleased to have Dr. Makowka come aboard and assist us with these timely medical products and solutions, especially with the National emphasis on change and improvement in the healthcare system. Digital and wireless solutions for the healthcare system are at the forefront of the current advancement and revolution in healthcare in this country and most parts of the world,” stated Michael Lutton, NPDT CEO.

Lutton continued, “Leonard’s deep relationships with the healthcare networks, academic institutions and physicians, and his familiarity with regulatory agencies at all government levels will assist NPDT in implementing and distributing its products and solutions in a timely manner. Leonard’s entrepreneurial and business experience since retiring from medical practice 15 years ago, will allow us to use his skills and network as we build and roll out our non-healthcare products and solutions, and grow our entire company.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.